The proportion of HLA-sensitized patients decreased in the Tac/MMF group ( 15.9 % at D0 and 6.7 % at M12 , p = 0.02 ) and remained stable in the CsA/AZA group ( 10.3 % at D0 and 8.9 % at M12 , p = 0.5 ) .